doxepin hydrochloride 25 mg
Doxepin Hydrochloride Capsules, USP are recommended for the treatment of: 1. Psychoneurotic patients with depression and/or anxiety. 2. depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol). 3. depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly). 4. Psychotic depressive disorders with associated anxiety including involutional depression and manic-depressive disorders. The target symptoms of psychoneurosis that respond particularly well to Doxepin Hydrochloride Capsules, USP include anxiety, tension, depression, somatic symptoms and concerns, sleep disturbances, guilt, lack of energy, fear, apprehension and worry. Clinical experience has shown that Doxepin Hydrochloride Capsules, USP is safe and well tolerated even in the elderly patient. Owing to lack of clinical experience in the pediatric population, Doxepin Hydrochloride Capsules, USP are not recommended for use in children under 12 years of age.
florida pharmaceutical products, llc
Related Pills
doxepin hydrochloride capsule
florida pharmaceutical products, llc
doxepin hydrochloride capsule
florida pharmaceutical products, llc
doxepin hydrochloride capsule
florida pharmaceutical products, llc
doxepin hydrochloride capsule
florida pharmaceutical products, llc
doxepin hydrochloride capsule
florida pharmaceutical products, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
DOXEPIN HYDROCHLORIDE capsules, USP are available containing
DOXEPIN HYDROCHLORIDE, USP equivalent to 10 mg, 25 mg, 50 mg, 75 mg or 100 mg of doxepin. The 10 mg capsule is a hard-shell, gelatin capsule with a buff opaque cap and buff opaque body, axially printed in black ink with "FPP" on cap and "162" on body, filled with white to off white granular powder. They are available as follows: Bottles of 100 capsules – NDC 71921-162-01 The 25 mg capsule is a hard-shell, gelatin capsule with an ivory opaque cap and white opaque body, axially printed with "FPP" on cap and "163'' on body in black ink, filled with white to off white granular powder. They are available as follows: Bottles of 100 capsules – NDC 71921-163-01 The 50 mg capsule is a hard-shell, gelatin capsule with an ivory opaque cap and ivory opaque body, axially printed with "FPP†on cap and "164" on body in black ink, filled with white to off white granular powder. They are available as follows: Bottles of 100 capsules – NDC 71921-164-01 The 75 mg capsule is a hard-shell, gelatin capsule with a bright light green opaque cap and bright light green opaque body, axially printed with "FPP" on cap and "165" on body in black ink, filled with white to off white granular powder. They are available as follows: Bottles of 100 capsules – NDC 71921-165-01 The 100 mg capsule is a hard-shell, gelatin capsule with a bright light green opaque cap and white opaque body, axially printed with "FPP" on cap and "166" on body in black ink, filled with white to off white granular powder. They are available as follows: Bottles of 100 capsules – NDC 71921-166-01
More pills like CAPSULE FPP 163